FDA Approves First Weight Loss Pill Version

Quick Smiles:

• The FDA has approved the first oral version of Wegovy, expanding access to popular GLP-1 weight loss drugs.
• Clinical trials show pill users lost up to 16.6% of their body weight on average after 64 weeks.
• The new pill, taken daily, offers a more familiar option for those uncomfortable with injections.

The FDA has given the green light to the first tablet form of Wegovy, making it the first oral GLP-1 drug for weight loss on the market. This important milestone offers people a daily alternative to the injectable treatments that have gained widespread attention for their effectiveness.

Clinical trial data published in the New England Journal of Medicine revealed that participants who took the highest dose of Wegovy’s pill version experienced significant weight loss—16.6% on average—after 64 weeks, compared to 2.2% in the placebo group.

Phase 3 results show that the pill’s effectiveness is comparable to the injectable version and opens up options for those seeking support in their weight loss journey.

“This is a meaningful step forward in the field,” said Dr. Christopher McGowan, a gastroenterologist and weight loss expert.

“It won’t replace injectables, but it broadens our tool kit in an important way.”

Dr. McGowan added, “Pills are familiar, nonintimidating and fit more naturally into most people’s routines. For many patients, a pill isn’t just easier, it’s psychologically more acceptable.”

The pill must be taken daily, first thing in the morning, on an empty stomach with a small amount of water. For the best results, sticking to this routine is key.

While questions remain about insurance coverage, the pill was also approved for lowering heart disease risk, potentially widening access for more people.

Novo Nordisk plans to make the pill widely available in January and has increased production to help prevent supply shortages.

Dr. McGowan noted that oral medications can be easier to manufacture, which may help steady the supply chain and keep hope high for those awaiting treatment.

If you or someone you know would enjoy uplifting health news and human stories, make sure to subscribe and share these Quick Smiles!

Source